InterCure Profit Margin

The latest profit margin for IRCLF is -13.22% as of December 2025. That compares with -28.38% in the prior-year period — up 53.4% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside InterCure's historical trend and sector peers before judging valuation or financial health.

Over the past year, IRCLF's profit margin moved from -28.38% to -13.22% — a 53.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in InterCure's valuation or profitability profile.

Against Healthcare companies, IRCLF currently prints -13.22% for profit margin, while the sector average sits near 13.89%. That is roughly 195.1% below the sector mean. Large gaps often invite a closer look at InterCure's growth, margins, and balance sheet.

Profit Margin shows how effectively InterCure converts resources into returns. At -13.22%, IRCLF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -28.38% in the prior-year period — up 53.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IRCLF's profit margin (-13.22%), review year-over-year change from -28.38%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.